Literature DB >> 7594072

Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography. Determination of extent of altered vascular reactivity.

R S Beanlands1, O Muzik, P Melon, R Sutor, S Sawada, D Muller, D Bondie, G D Hutchins, M Schwaiger.   

Abstract

OBJECTIVES: The aim of this study was to evaluate patients with coronary artery disease to 1) determine the relation between flow reserve measured by nitrogen-13 (N-13) ammonia kinetic modeling and stenosis severity assessed by quantitative angiography, and 2) examine whether flow reserve is impaired in regions supplied by vessels without significant angiographic disease.
BACKGROUND: With the advent of new therapeutic approaches for coronary disease, an accurate noninvasive approach for absolute quantification of flow and flow reserve is needed to evaluate functional severity and extent of atherosclerosis. Nitrogen-13 ammonia kinetic modeling may permit such evaluation.
METHODS: Twenty-seven subjects were classified into three groups: group 1 = 5 young volunteers: group 2 = 7 middle-aged volunteers; and group 3 = 15 patients with coronary artery disease. Dynamic N-13 ammonia positron emission tomographic imaging was performed at rest and during adenosine infusion. A three-compartment model was fit to regional N-13 ammonia kinetic data to determine myocardial flow. Group 3 patients underwent quantitative coronary angiography.
RESULTS: The regional blood flow results in patients with coronary disease were classified into four subgroups: no significant detectable disease and mild (50% to 69.9% area stenosis), moderate (70% to 94.9% area stenosis) or severe (95% to 100% area stenosis) coronary disease. Flow reserve was 2.95 +/- 0.65; 2.09 +/- 0.47; 2.02 +/- 0.51; 1.3 +/- 0.32, respectively (p < or = 0.01 except mild vs. moderate). Flow reserve was correlated with percent area stenosis (r = -0.56) and minimal lumen diameter (r = 0.75). In volunteers (groups 1 and 2), flow reserves were greater than in segments without detectable disease in group 3 patients (4.10 +/- 0.71 and 3.79 +/- 0.42, respectively, vs. 2.88 +/- 0.56, p < or = 0.02).
CONCLUSIONS: The functional severity of coronary disease measured by N-13 ammonia positron emission tomography varied for a given stenosis but was significantly related to angiographic severity. Among patients with coronary disease, myocardial regions without significant angiographic stenoses displayed reduced flow reserve than did regions in control subjects, indicating that vascular reactivity was more diffusely impaired in group 3 than was suggested by angiography. Noninvasive quantification of myocardial flow reserve using dynamic N-13 ammonia positron emission tomography yields important functional data that permit definition of the extent of disease even when disease is not apparent by angiography.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7594072     DOI: 10.1016/0735-1097(95)00359-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  40 in total

1.  Lake Tahoe invitation meeting 2002.

Authors: 
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

2.  Assessment of coronary flow reserve and microcirculation: a clinical perspective.

Authors:  Roxana Campisi; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2004 Jan-Feb       Impact factor: 5.952

3.  Regional myocardial perfusion defects during exercise, as assessed by three dimensional integration of morphology and function, in relation to abnormal endothelium dependent vasoreactivity of the coronary microcirculation.

Authors:  T H Schindler; E Nitzsche; N Magosaki; I Brink; M Mix; M Olschewski; U Solzbach; H Just
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

Review 4.  PET: Is myocardial flow quantification a clinical reality?

Authors:  Antti Saraste; Sami Kajander; Chunlei Han; Sergey V Nesterov; Juhani Knuuti
Journal:  J Nucl Cardiol       Date:  2012-10       Impact factor: 5.952

Review 5.  The clinical utility of assessing myocardial blood flow using positron emission tomography.

Authors:  Maria Cecilia Ziadi; Rob S B Beanlands
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

6.  Early insights of cardiac risk and treatment response with quantitative PET monitoring of coronary-specific endothelial dysfunction and myocardial perfusion reserve.

Authors:  Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2010-12       Impact factor: 5.952

Review 7.  Reasons and implications of agreements and disagreements between coronary flow reserve, fractional flow reserve, and myocardial perfusion imaging.

Authors:  Manish Motwani; Mahsaw Motlagh; Anuj Gupta; Daniel S Berman; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2015-12-29       Impact factor: 5.952

8.  Myocardial blood flow: Putting it into clinical perspective.

Authors:  Thomas Hellmut Schindler
Journal:  J Nucl Cardiol       Date:  2015-12-28       Impact factor: 5.952

Review 9.  Advances in positron emission tomography.

Authors:  Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

10.  Cine CT for attenuation correction in cardiac PET/CT.

Authors:  Adam M Alessio; Steve Kohlmyer; Kelley Branch; Grace Chen; James Caldwell; Paul Kinahan
Journal:  J Nucl Med       Date:  2007-05       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.